PM
PMEDF.US Predictmedix Inc
- Market cap
- USD 4.14M
- P/E
- -
- P/B
- 18.77x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.
Is PMEDF.US undervalued?
Graham numberThe Graham number of Predictmedix Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Predictmedix Inc fundamental analysis
No fundamental analysis for Predictmedix Inc yet.
Predictmedix Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Predictmedix Inc
QScreen AI Inc. develops artificial intelligence powered technologies for general workplace health and safety, and health care industry. It operates through Workplace Health and Safety, and Healthcare segments. The company offers infectious disease symptom screening solutions to identify persons who test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. It also develops alcohol and cannabis impairment detection screening scanners …
Full company profilePredictmedix Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Predictmedix Inc annual financial statements
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | - | 0.00 | 49.6K | 35.0K | 35.0K | 0.00 | 0.00 | 0.00 | - |
| Gross Profit | -14.8K | -1.67K | -1.67K | 26.6K | 26.6K | -168K | -107K | -19.9K | - |
| Operating Income | -314K | -817K | -817K | -1.65M | -2.06M | -1.75M | -788K | -1.19M | -812K |
| EBITDA | -310K | -756K | -756K | -1.80M | -1.91M | -1.75M | -788K | -1.17M | -812K |
| Net Income | -275K | -2.29M | -2.29M | -1.88M | -2.07M | -1.99M | -1.18M | -1.17M | -873K |
| EPS | 0.00 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 |
| Balance Sheet | |||||||||
| Total Assets | 1.73M | 1.67M | 1.00M | 718K | 718K | 481K | 132K | 511K | 764K |
| Total Liabilities | 47.1K | 83.1K | 135K | 871K | 871K | 625K | 1.45M | 1.27M | 1.42M |
| Shareholders' Equity | 1.73M | 1.58M | 868K | -153K | -153K | -144K | -1.32M | -763K | -657K |
| Cash & Short-term Investments | 1.56M | 1.49M | 480K | 211K | 79.3K | 36.9K | 0.00 | 312K | 396K |
| Total Debt | - | - | 15.2K | 37.9K | 37.9K | - | - | - | - |
| Cash Flow | |||||||||
| Operating Cash Flow | -345K | -832K | -1.08M | -534K | -534K | -1.64M | -36.9K | -1.13M | -919K |
| Capital Expenditure | 15.9K | 13.4K | 195K | 145K | 145K | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -361K | -845K | -1.27M | -679K | -679K | -1.64M | -36.9K | -1.13M | -919K |
| Ratios | |||||||||
| ROE | -15.9% | -144.7% | -263.9% | - | - | - | - | - | - |
| ROA | -15.9% | -137.5% | -228.3% | -262.2% | -288.1% | -414.2% | -891.0% | -228.1% | -114.2% |
| Net Profit Margin | - | - | -4,616.3% | -5,374.6% | -5,904.5% | - | - | - | - |
| Debt to Equity | - | - | 0.02x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Predictmedix Inc dividends
Predictmedix Inc has not paid dividends in the last 8 fiscal years.
Who owns Predictmedix Inc
- Insiders 12.98%
- Institutions 0.00%
- Public & others 87.02%
- Shares outstanding 230M
- Free float 200M
Predictmedix Inc company profile
- Company name
- Predictmedix Inc
- Ticker
- PMEDF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- January
- Address
- Scotia Plaza, Toronto, ON, Canada, M5H 3Y2
- Phone
- 647 889 6916
- Website
- q-screen.ai
About Predictmedix Inc
QScreen AI Inc. develops artificial intelligence powered technologies for general workplace health and safety, and health care industry. It operates through Workplace Health and Safety, and Healthcare segments. The company offers infectious disease symptom screening solutions to identify persons who test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. It also develops alcohol and cannabis impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. QScreen AI Inc. has a strategic alliance with Pacific Mechatronics Pvt. Ltd. to scale AI health screening across defense sectors. The company was formerly known as Predictmedix AI Inc. and changed its name to QScreen AI Inc. in January 2026. QScreen AI Inc. is headquartered in Toronto, Canada.
Predictmedix Inc management
3- Mr. Sheldon KalesPresident, CEO & Director · born 1955
- Dr. Rahul Kushwah B.Sc., Ph.D.COO & Director · born 1983
- Mr. Guru SeghalManaging Director for India Operations